Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

Article CLOSED
Behe, M.; Kluge, G.; Becker, W.; Gotthardt, M.; Behr, T.M.;

Uptake of radiolabeled peptides in the kidneys may obscure abdominal tumors in radiopeptide scintigraphy. This problem is much more pronounced in peptide receptor radionuclide therapy (i.e., radiopeptide therapy), possibly leading to renal damage or even failure. Cation... View more
Share - Bookmark

  • Download from
  • Cite this publication